QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $22 | $7 | $0 | $0 |
| - Cash | $1 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $1 | $4 |
| Enterprise Value | $20 | $8 | -$1 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$372,938 |
| % Margin | – | – | – | – |
| EBITDA | $36,296 | -$5 | -$12 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$6 | -$13 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.24 | -3.45 | -16.13 | -19.57 |
| % Growth | 64.1% | 78.6% | 17.6% | – |
| Operating Cash Flow | -$3 | -$3 | -$2 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$3 | -$2 | -$1 |